Dr. Lewis C. Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, has been awarded the 2016 Wolf Prize in Medicine for his research discoveries.
The first-ever 'disease in a Petri dish' platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.
Weill Cornell Medicine has entered into an agreement with Tahoe Investment Group to assist in the development of an international hospital in Shanghai, China.
Researchers from Weill Cornell Medicine and the U.S. government have created a checklist to identify patients who develop a common and potentially fatal secondary meningitis infection.
A new study shows the cost of forgoing antibiotics on dairy farms would average out to $61 per cow annually and is studying the impact such a decision would have.
Ultrasmall Cornell dots armed with antibodies are another weapon in the fight against cancer, says Uli Wiesner, professor of materials science and engineering.
In the second season of the Inside Medicine online video series, Weill Cornell Medicine chronicles three stories emblematic of the institution’s dedication to translational research.
An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.